EntrepreneurialCheck
Enrique Ibarra estimated net worth profile

Enrique Ibarra net worth

Enrique Ibarra Net Worth 2026 (Estimated) · Founder at My NextDerma · YC W21
est. wealth $6.67M

Quick answer

Enrique Ibarra's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Enrique Ibarra is Founder at My NextDerma. My NextDerma valuation.

Enrique Ibarra is Founder at My NextDerma (YC W21). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameEnrique Ibarra
RoleFounder
CompanyMy NextDerma
YC batchW21
Est. company val$20.0M
Assumed ownership33.3%
Est. paper wealth / net worth$6.67M
$4.67M – $10.0M
  • Company status: Active
  • Region: Unspecified
  • Industries: Healthcare, Consumer Health and Wellness
  • Team size: 12
  • Website: https://mynextderma.com

Who is Enrique Ibarra?

Enrique Ibarra is a founder of My NextDerma, which was part of the Y Combinator W21 batch.

Highlights:

  • Y Combinator W21
  • My NextDerma

About My NextDerma

Dermatologist 👩🏻‍⚕️ virtual clinic in LATAM, with great dermatologists that consult, prescribe and send treatment to your doorstep In 🇲🇽 Mexico 8 out of 10 teenagers have acne, and there is only a ratio of 1 Dermatologist 👨🏽‍⚕️ per 50,000 🌎 population.

FAQ: Enrique Ibarra net worth and My NextDerma valuation

What is Enrique Ibarra's net worth?

Enrique Ibarra's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Enrique Ibarra is Founder at My NextDerma. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is My NextDerma valuation?

My NextDerma's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Enrique Ibarra's role?

Enrique Ibarra is Founder at My NextDerma, a Y Combinator-backed startup (batch W21).